These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease. Salazar AM; Masters CL; Gajdusek DC; Gibbs CJ Ann Neurol; 1983 Jul; 14(1):17-26. PubMed ID: 6351721 [TBL] [Abstract][Full Text] [Related]
8. Combined Creutzfeldt-Jakob/ Alzheimer's Disease Cases are Important in Search for Microbes in Alzheimer's Disease. Bastian FO J Alzheimers Dis; 2017; 56(3):867-873. PubMed ID: 28059790 [TBL] [Abstract][Full Text] [Related]
9. Creutzfeldt-Jakob disease: procedures for handling diagnostic and research materials. Bastian FO; Jennings RA Infect Control; 1984 Jan; 5(1):48-50. PubMed ID: 6358089 [No Abstract] [Full Text] [Related]
10. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent. Taguchi F; Tamai Y; Uchida K; Kitajima R; Kojima H; Kawaguchi T; Ohtani Y; Miura S Arch Virol; 1991; 119(3-4):297-301. PubMed ID: 1877889 [TBL] [Abstract][Full Text] [Related]
11. Growth and spread of causative agent of Creutzfeldt-Jakob disease in intraperitoneally infected mice. Chino F; Ohkawa T Jpn J Med Sci Biol; 1990 Dec; 43(6):197-208. PubMed ID: 2101136 [TBL] [Abstract][Full Text] [Related]
12. Reply to: Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report. Hayashi Y; Inuzuka T J Neurol Sci; 2017 Apr; 375():489. PubMed ID: 28258726 [No Abstract] [Full Text] [Related]
13. Creutzfeldt-Jakob disease with demonstration of virus-like particles. Shibayama Y; Sakaguchi Y; Nakata K; Goto T; Nakai M; Takai T; Shirakata S Acta Pathol Jpn; 1982 Jul; 32(4):695-702. PubMed ID: 7051752 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of the Creutzfeldt-Jakob disease agent. Tamai Y; Taguchi F; Miura S Ann Neurol; 1988 Sep; 24(3):466-7. PubMed ID: 3067657 [No Abstract] [Full Text] [Related]
15. Reply to: The Letter to be published with the Letter, Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report. Yaguchi H; Takeuchi A; Horiuchi K; Takahashi I; Shirai S; Akimoto S; Satoh K; Moriwaka F; Yabe I; Sasaki H J Neurol Sci; 2017 Apr; 375():490-491. PubMed ID: 28259353 [No Abstract] [Full Text] [Related]
16. Membrane filtration and the Creutzfeldt-Jakob agent. Taylor DM Lancet; 1985 Dec 21-28; 2(8469-70):1430-1. PubMed ID: 2867425 [No Abstract] [Full Text] [Related]
17. A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the 'panencephalopathic type' disease. Mori S; Hamada C; Kumanishi T; Fukuhara N; Ichihashi Y; Ikuta F; Miyatake T; Tsubaki T Neurology; 1989 Oct; 39(10):1337-42. PubMed ID: 2677833 [TBL] [Abstract][Full Text] [Related]
18. Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report. Yaguchi H; Takeuchi A; Horiuchi K; Takahashi I; Shirai S; Akimoto S; Satoh K; Moriwaka F; Yabe I; Sasaki H J Neurol Sci; 2017 Jan; 372():444-446. PubMed ID: 27838004 [No Abstract] [Full Text] [Related]
19. Phenolized formalin may not inactivate Creutzfeldt-Jakob disease infectivity. Taylor DM Neuropathol Appl Neurobiol; 1989; 15(6):585-6. PubMed ID: 2693993 [No Abstract] [Full Text] [Related]
20. Subcellular distribution of the transmissible agent in Creutzfeldt-Jakob disease mouse brain. Tamai Y; Kojima H; Ohtani Y; Uchida K; Taguchi F; Kawaguchi T; Miura S; Tateishi J Microbiol Immunol; 1989; 33(1):35-42. PubMed ID: 2659945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]